跳至主要内容
临床试验/NCT07602751
NCT07602751尚未招募1 期

Fecal Microbiota Transplantation for the Treatment of Steroid-refractory Graft-versus-host Disease.

Bambino Gesù Hospital and Research Institute3 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2026年5月18日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
20
试验地点
3

研究概览

简要总结

This is a pilot, prospective, non-profit, multicenter, uncontrolled, open-label study to evaluate the safety and feasibility of FMT in patients aged between 3 months and 25 years suffering from acute intestinal GVHD resistant to conventional steroid therapy.

Eligible patients will receive 1-3 FMT via naso-jejunal tube or endoscopy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Months 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of hematological disease, malignant or non-malignant;
  • Patients undergoing allogeneic stem cell transplantation from a familial or unrelated donor;
  • Presence of acute GVHD with intestinal involvement (grade II-IV), steroid-resistant (i.e., with progression after 3 days of high-dose steroid therapy (methylprednisolone > 2 mg/kg), no response after 7 days, progression during steroid tapering, or failure to achieve remission on day 28 from the start of steroid therapy), for those who have no indication for other second- or third-line therapies;
  • Signed informed consent.

排除标准

  • Presence of concurrent bacterial infections requiring systemic antibiotic therapy;
  • Positivity for anti-HIV or anti-HCV antibodies, or for HbsAg with HBV-DNA positive by PCR;
  • Presence of severe mucositis;
  • History of chronic inflammatory bowel disease.

研究者

发起方
Bambino Gesù Hospital and Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验